OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Aberrant DNA Methylation in Acute Myeloid Leukemia and Its Clinical Implications
Xian‐Wen Yang, Molly Pui Man Wong, Ray Kit Ng
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4576-4576
Open Access | Times Cited: 85
Xian‐Wen Yang, Molly Pui Man Wong, Ray Kit Ng
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4576-4576
Open Access | Times Cited: 85
Showing 1-25 of 85 citing articles:
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose, Joshua T. Burgess, Kenneth J. O’Byrne, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 520
Maddison Rose, Joshua T. Burgess, Kenneth J. O’Byrne, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 520
Drug Resistance Mechanisms of Acute Myeloid Leukemia Stem Cells
Jialan Niu, Danyue Peng, Lingbo Liu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 43
Jialan Niu, Danyue Peng, Lingbo Liu
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 43
Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia
Gus O. Nwosu, David M. Ross, Jason A. Powell, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11
Gus O. Nwosu, David M. Ross, Jason A. Powell, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11
An Epigenetic Manifestation of Alzheimer's Disease: DNA Methylation
Boyi Feng, Junli Zheng, Ying Cai, et al.
Actas Españolas de Psiquiatría (2024) Vol. 52, Iss. 3, pp. 365-374
Open Access | Times Cited: 7
Boyi Feng, Junli Zheng, Ying Cai, et al.
Actas Españolas de Psiquiatría (2024) Vol. 52, Iss. 3, pp. 365-374
Open Access | Times Cited: 7
The Impact of Epigenetic Modifications in Myeloid Malignancies
Deirdra Venney, Adone Mohd-Sarip, Ken Mills
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 5013-5013
Open Access | Times Cited: 33
Deirdra Venney, Adone Mohd-Sarip, Ken Mills
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 5013-5013
Open Access | Times Cited: 33
DNA methylation: a saga of genome maintenance in hematological perspective
Saran Chattopadhyaya, Somnath Ghosal
Human Cell (2022) Vol. 35, Iss. 2, pp. 448-461
Closed Access | Times Cited: 23
Saran Chattopadhyaya, Somnath Ghosal
Human Cell (2022) Vol. 35, Iss. 2, pp. 448-461
Closed Access | Times Cited: 23
Cell-free DNA 5-hydroxymethylcytosine is an emerging marker of acute myeloid leukemia
Jianming Shao, Sihan Wang, Diana C. West-Szymanski, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Jianming Shao, Sihan Wang, Diana C. West-Szymanski, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
m5C regulator‐mediated methylation modification patterns and tumor microenvironment infiltration characteristics in acute myeloid leukemia
Qiang Wen, ShouJun Wang, Lili Hong, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Qiang Wen, ShouJun Wang, Lili Hong, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 5
Targeting integrins in drug‐resistant acute myeloid leukaemia
Heather Ogana, Samantha Hurwitz, Nathan Wei, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 2, pp. 295-316
Open Access | Times Cited: 12
Heather Ogana, Samantha Hurwitz, Nathan Wei, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 2, pp. 295-316
Open Access | Times Cited: 12
DNA methylation-based prognostic biomarkers of acute myeloid leukemia patients
Linjun Hu, Yuling Gao, Zhan Shi, et al.
Annals of Translational Medicine (2019) Vol. 7, Iss. 23, pp. 737-737
Open Access | Times Cited: 32
Linjun Hu, Yuling Gao, Zhan Shi, et al.
Annals of Translational Medicine (2019) Vol. 7, Iss. 23, pp. 737-737
Open Access | Times Cited: 32
LncRNA USP30-AS1 promotes the survival of acute myeloid leukemia cells by cis-regulating USP30 and ANKRD13A
Wei Zhou, Shilin Xu, Tingfen Deng, et al.
Human Cell (2021) Vol. 35, Iss. 1, pp. 360-378
Open Access | Times Cited: 25
Wei Zhou, Shilin Xu, Tingfen Deng, et al.
Human Cell (2021) Vol. 35, Iss. 1, pp. 360-378
Open Access | Times Cited: 25
ALKBH3-mediated m1A demethylation promotes the malignant progression of acute myeloid leukemia by regulating ferroptosis through the upregulation of ATF4 expression
Xin Liu, Xinghua Pan
Hematology (2025) Vol. 30, Iss. 1
Open Access
Xin Liu, Xinghua Pan
Hematology (2025) Vol. 30, Iss. 1
Open Access
DNA methylation inhibitors adverse reaction characteristic analysis: an analysis based on the European spontaneous adverse event reporting system
Xia Zhang, Yuyu Liu, Qinming Hou, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Xia Zhang, Yuyu Liu, Qinming Hou, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Treating Hematological Malignancies With OR ‐2100, an Orally Bioavailable Prodrug of Decitabine
Tatsuro Watanabe, Keisuke Kidoguchi, Shinya Kimura
Cancer Science (2025)
Open Access
Tatsuro Watanabe, Keisuke Kidoguchi, Shinya Kimura
Cancer Science (2025)
Open Access
Mechanism of non-coding RNA regulation of DNMT3A
Jonathan E. Sandoval, Nancy V. N. Carullo, Aaron J. Salisbury, et al.
Epigenetics & Chromatin (2025) Vol. 18, Iss. 1
Open Access
Jonathan E. Sandoval, Nancy V. N. Carullo, Aaron J. Salisbury, et al.
Epigenetics & Chromatin (2025) Vol. 18, Iss. 1
Open Access
Acute myeloid leukemia-derived extracellular vesicles induced DNA methylation changes responsible for inflammatory program in normal hematopoietic stem progenitor cells
Daniela Lamorte, Giovanni Calice, Stefania Trino, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Daniela Lamorte, Giovanni Calice, Stefania Trino, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Epigenetic silencing of DDIT3 gene and its relationship with imatinib resistance, disease progression and smoking status among patients with chronic myeloid leukemia
Maryam Foroutanjazi, Mohammad Hamid, Mitra Salehi, et al.
Deleted Journal (2025) Vol. 35, Iss. 1, pp. 14-23
Closed Access
Maryam Foroutanjazi, Mohammad Hamid, Mitra Salehi, et al.
Deleted Journal (2025) Vol. 35, Iss. 1, pp. 14-23
Closed Access
Clinicopathological and global methylation profiling of acute myeloid leukemia with mutations in NPM1 and clonal hematopoiesis-related genes
Mostafa Elhodaky, Drew Duckett, Lucas Santana‐Santos, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-8
Closed Access
Mostafa Elhodaky, Drew Duckett, Lucas Santana‐Santos, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-8
Closed Access
Acute Myeloid Leukemia Genome Characterization Study and Subtype Classification Employing Feature Selection and Bayesian Networks
Zhenzhen Li, Jingwen Li, S. Z. Li, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1067-1067
Open Access
Zhenzhen Li, Jingwen Li, S. Z. Li, et al.
Biomedicines (2025) Vol. 13, Iss. 5, pp. 1067-1067
Open Access
Prognostic impact of methylation-related gene mutations in elderly acute myeloid leukemia: a real-world retrospective analysis
Yi Chen, Zhengjun Wu, Yanxin Chen, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Yi Chen, Zhengjun Wu, Yanxin Chen, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Immunotherapeutic Potential of m6A-Modifiers and MicroRNAs in Controlling Acute Myeloid Leukaemia
Sunil Kumar, Ravinder Nagpal, Amit Kumar, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 690-690
Open Access | Times Cited: 22
Sunil Kumar, Ravinder Nagpal, Amit Kumar, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 690-690
Open Access | Times Cited: 22
Pediatric acute myeloid leukemia: Insight into genetic landscape and novel targeted approaches
Nataša Tos̆ić, Irena Marjanović, Jelena Lazić
Biochemical Pharmacology (2023) Vol. 215, pp. 115705-115705
Closed Access | Times Cited: 9
Nataša Tos̆ić, Irena Marjanović, Jelena Lazić
Biochemical Pharmacology (2023) Vol. 215, pp. 115705-115705
Closed Access | Times Cited: 9
Molecular landscape of the interleukin-40 encoding gene, C17orf99, in patients with acute myeloid leukemia
Mustafa A. Bashi, Ali H. Ad’hiah
Gene (2024) Vol. 904, pp. 148214-148214
Closed Access | Times Cited: 3
Mustafa A. Bashi, Ali H. Ad’hiah
Gene (2024) Vol. 904, pp. 148214-148214
Closed Access | Times Cited: 3
Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors
Melisa Tecik, Aysun Adan
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 6, pp. 719-751
Open Access | Times Cited: 3
Melisa Tecik, Aysun Adan
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 6, pp. 719-751
Open Access | Times Cited: 3
Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review
Dimakatso Alice Senthebane, Chelene Ganz, Nicholas Ekow Thomford, et al.
(2020)
Open Access | Times Cited: 21
Dimakatso Alice Senthebane, Chelene Ganz, Nicholas Ekow Thomford, et al.
(2020)
Open Access | Times Cited: 21
